By JUAN SAMARAS
Ask how much Ozempic costs. The honest answer ranges from $25 a month to $1,100 a month, and every figure in that range is real, published, and defensible. A sentence that covers a margin of forty-four times is not a price. It’s a fog and patients make four-figure annual decisions inside it.
I run GLP Chart, an independent GLP-1 price index. The index shows that “Ozempic price” fails as a concept for three reasons. The molecule is sold in five forms under four names. Each shape is sold through different channels at different prices. And the advertised price rarely survives until the fourth month.
One molecule, five shapes.
Ozempic is semaglutide, branded for type 2 diabetes. The same molecule is Wegovy when it was approved for weight loss, sold as a weekly pen and, since 2026, as a daily pill. It is Rybelsus in the oldest oral form. And 503A compounding pharmacies still sell it as compounded semaglutide when rules allow it, although FDA compounding restrictions and lawsuits from manufacturers narrowed that market until 2025 and 2026.
When someone says “Ozempic price,” they almost always mean “how much will semaglutide cost me.” Those are different questions with different answers.
Same molecule, seven prices
Here is the current dashboard of our price index. Each cash figure comes from the pages published by the seller. The last two rows are copays.
| The same molecule, purchased as | Monthly cost |
| Ozempic, cash at the pharmacy counter. | $900 to $1,100 |
| Wegovy pen, directly from Novo Nordisk (NovoCare) | $349 for each maintenance dose |
| Wegovy pill, directly from NovoCare | $149 initial, $299 maintenance, $249 with 12-month prepaid |
| Wegovy pill through a telehealth program | $373 to $448 once membership fee hits the top |
| Compounded semaglutide, the cheapest fixed price program | $178 all-inclusive ($79 membership plus $99 medication for each dose) |
| With commercial insurance, prior authorization | usually a copay of $25 to $50 |
| In Medicare since July 1, under the CMS GLP-1 bridge | $50 for Wegovy forms; Ozempic for diabetes remains in Part D |
Each row is “the price of Ozempic” in someone’s mouth.
One row deserves a second look. Novo Nordisk reduced the price of its own direct-to-consumer pen from $499 to $349 in November 2025, a 30 percent cut. The previous drugstore selling price did not move. The gap between those two ranks is not a market inefficiency. It’s the business model.
The membership layer
A telehealth program that prescribes the Wegovy pill puts you at the same NovoCare price of $299 that you could get yourself. What the program adds is a membership fee, $74 to $149 per month across all programs we track, which covers the prescribing doctor, application, and refill logistics. Whether that rate allows you to buy something you need is a fair question, and it’s a different question at $74 than at $149.
Two design options on this layer deserve more attention than they receive because they work together.
First, the price of the initial dose. The pill that costs $149 for the first month costs $299 for the dose that you are actually going to continue taking.
Secondly, the bulls. Eight of the 29 programs we track commit patients to a contract, three of them for a full year. A teaser price plus a contract is a retention machine, not a discount.
The price is also granular enough that even sellers can interact with it line by line. This week, Ro’s communications team wrote to point out that an annual prepaid drug plan reduces the price of Wegovy pills to $249 a month. They were right. Their published pricing page confirms this and our listing now says so. That level of specificity is needed to set a program’s single price for one form of a molecule. “The price of Ozempic” would never survive contact with this market.
What to check before paying for anything
Five questions, in order:
- What form of molecule is the quote referring to: Ozempic, a Wegovy pen or pill, Rybelsus, or a compound?
- Is that the starting dose or the maintenance dose? Ask how much it costs for month four, not month one.
- Does the number include the membership fee or is it billed separately?
- Can you go month to month or are you signing a contract?
- If you have insurance, does anyone do prior authorization? A $25 copay beats any cash price on this page.
“Ozempic price” will continue to make headlines because it is short. But it hides the two numbers that decide whether the treatment is affordable: the total maintenance dose after the advance expires and the accrued fee on top of the drug. Name the form, name the channel, name the month. Then you have a price.
John Samaras is the founder and editor of LPG Chartwhich tracks what each major GLP-1 program charges, is verified every Monday and the methodology is public. No program pays to be listed or ranked.
